Peptide amidation: A push me, don't pull you for the morbidities in sleep apnea

Journal of Applied Physiology

Volumn 106, Issue 1, 2009, Pages 3-4

  Veasey, Sigrid ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; CALCITONIN GENE RELATED PEPTIDE; CHOLECYSTOKININ; CORTICOTROPIN RELEASING FACTOR; GONADORELIN; GROWTH HORMONE RELEASING FACTOR; NEUROPEPTIDE Y; OXYTOCIN; PEPTIDE; REACTIVE OXYGEN METABOLITE; SUBSTANCE P; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOPRESSIN;

AMIDATION; AROUSAL; EDITORIAL; HUMAN; HYPERCAPNIA; HYPOXEMIA; MORBIDITY; NONHUMAN; OXIDATIVE STRESS; OXYGENATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SLEEP APNEA SYNDROME; WAKEFULNESS;

AMIDINE-LYASES; ANIMALS; ANOXIA; BRAIN STEM; ENZYME ACTIVATION; HUMANS; MIXED FUNCTION OXYGENASES; MULTIENZYME COMPLEXES; NEUROPEPTIDE Y; PROTEIN PROCESSING, POST-TRANSLATIONAL; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; SLEEP APNEA SYNDROMES; SUBSTANCE P;

EID: 58649115841     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.91422.2008     Document Type: Editorial

References (13)

1. Barcelo A, Barbe F, Llompart E, de la Pena M, Duran-Cantolla J, Ladaria A, Bosch M, Guerra L, Agusti AG. Neuropeptide Y and leptin in patients with obstructive sleep apnea syndrome: role of obesity. Am J Respir Crit Care Med 171: 183-187, 2005.
2. El-Ad B, Lavie P. Effect of sleep apnea on cognition and mood. Int Rev Psychiatry 17: 277-282, 2005.
3. Farre R, Montserrat JM, Navajas D. Morbidity due to obstructive sleep apnea: insights from animal models. Curr Opin Pulm Med 14: 530-536, 2008.
4. Kumar GK, Rai V, Sharma SD, Ramakrishnan DP, Peng YJ, Sou-vannakitti D, Prabhakar NR. Chronic intermittent hypoxia induces hypoxia-evoked catecholamine efflux in adult rat adrenal medulla via oxidative stress. J Physiol 575: 229-239, 2006.
5. Mueller GP, Driscoll WJ. α-Amidated peptides: approaches for analysis. Methods Mol Biol 446: 67-84, 2008.
6. Pierobon A, Giardini A, Fanfulla F, Callegari S, Majani G. A multidimensional assessment of obese patients with obstructive sleep apnoea syndrome (OSAS): a study of psychological, neuropsychological and clinical relationships in a disabling multifaceted disease. Sleep Med. In press.
7. Punjabi NM, Shahar E, Redline S, Gottlieb DJ, Givelber R, Resnick HE. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol 160: 521-530, 2004.
8. Remmers JE, deGroot WJ, Sauerland EK, Anch AM. Pathogenesis of upper airway occlusion during sleep. J Appl Physiol 44: 931-938, 1978.
9. Ruohonen ST, Pesonen U, Moritz N, Kaipio K, Roytta M, Koulu M, Savontaus E. Transgenic mice overexpressing neuropeptide Y in noradrenergic neurons: a novel model of increased adiposity and impaired glucose tolerance. Diabetes 57: 1517-1525, 2008.
10. 9a. Sharma SD, Raghuraman G, Lee MS, Prabhakar NR, Kumar GK. Intermittent hypoxia activates peptidylglycine α-amidating monooxygenase in rat brain stem via reactive oxygen species-mediated proteolytic processing. J Appl Physiol. First published September 25, 2008; doi:10.1152/ japplphysiol.90702.2008.
11. Smith PL, Wise RA, Gold AR, Schwartz AR, Permutt S. Upper airway pressure-flow relationships in obstructive sleep apnea. J Appl Physiol 64: 789-795, 1988.
12. Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A, Daniels S, Floras JS, Hunt CE, Olson LJ, Pickering TG, Russell R, Woo M, Young T. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation scientific statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing, in collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation 118: 1080-1111, 2008.
13. Ursavas A, Karadag M, Ilcol YO, Burgazlioglu B, Ercan I, Gozu RO. Relationship between serum substance P levels and daytime sleepiness in obstructive sleep apnea syndrome. Chest 131: 1400-1405, 2007.